{
    "nctId": "NCT03163316",
    "briefTitle": "The Role of Magnetic Resonance Imaging in Assessment of Axillary Lymph Nodes Metastasis in Breast Cancer Patients.",
    "officialTitle": "The Role of Unenhanced Magnetic Resonance Imaging in Quantitative Assessment of Metastatic Involvement of Axillary Lymph Nodes in Patients With Breast Cancer: Observational Descriptive Study.",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer Female",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 30,
    "primaryOutcomeMeasure": "Accuracy of unenhanced magnetic resonance imaging in assessment of axillary lymph node metastasis in breast cancer patients.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n- 1) Patients who proved positive for primary breast cancer by histopathology with axillary lymph nodes detected clinically or with superficial ultrasound on both axillae.\n\n2) The included lymph nodes with minimal axial diameter (4mm).\n\nExclusion Criteria:\n\n* 1)Patients who have a heart pacemaker as they are absolutely contraindicated for magnetic resonance imaging.\n\n  2) Patients with severe claustrophobia. 3) Patients undergoing any type of neoadjuvant chemo-, immune- or endocrine therapy.\n\n  4) Patients with history of axillary surgery or treatment. 5) Patients with recurrent axillary disease.",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}